Condition: HIV Disease Progression · Sponsor: Population Health Research Institute
A double blinded, placebo-controlled, multicenter trial to evaluate effectiveness of azithromycin prophylaxis on mortality in advanced HIV.
This description comes directly from the study's public registry record.
REVIVE Study Coordinator · 905-297-3479 · revive@phri.ca
Always discuss trial participation with your own doctor first.
| Centre Intégré de Recherches Biocliniques d'Abidjan (CIRBA) | Abidjan, Côte d’Ivoire | Not Yet Recruiting |
| Centre médical de suivi des donneurs de sang (CMSDS) | Abidjan, Côte d’Ivoire | Not Yet Recruiting |
| Unité de Soins Ambulatoires et de conseils (USAC) | Abidjan, Côte d’Ivoire | Not Yet Recruiting |
| Adama Hospital Medical College | Ādama, Ethiopia | Recruiting |
| Asella Referral and Teaching Hospital | Āsela, Ethiopia | Recruiting |
| Jimma University Hospital | Jimma, Ethiopia | Recruiting |
| Tigray health research institute (THRI) | Mek'ele, Ethiopia | Not Yet Recruiting |
| Komfo Anokye Teaching Hospital | Kumasi, Ghana | Not Yet Recruiting |
| Kumasi South Hospital | Kumasi, Ghana | Recruiting |
| Suntreso Government Hospital | Kumasi, Ghana | Recruiting |
| Lilongwe Medical Relief Fund/UNC Project | Lilongwe, Malawi | Not Yet Recruiting |
| Faculty of Medicine, Eduardo Mondlane University | Maputo, Mozambique | Not Yet Recruiting |
+ 40 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05580666